Biofrontera Inc. (Nasdaq: BFRI Patent allowed!

Company Name: Biofrontera Inc. 

Ticker: (BFRI)

Exchange:...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more

trending

Petros Pharma (PTPI) to launch an OTC Erectile dysfu...
Voce Capital is Buying Cutera Inc. (NASDAQ:CUTR) Shares
PRAX Stock Price has been crashing, can it go bounce...

Company Name: Biofrontera Inc. 

Ticker: (BFRI)

Exchange: NASDAQ

Website: www.biofrontera-us.com

Company Summary: 

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.

Why did it go up over 100%?

WOBURN, Mass., Dec. 08, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Biofrontera Pharma GmbH’s U.S. patent number 17/215,785 (‘785 patent), titled “Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination device,” which protects a number of innovations relating to the RhodoLED XL lamp.

WOBURN, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the first subject has been enrolled in the Phase 2b study performed by Biofrontera Bioscience GmbH to evaluate the safety and efficacy of Ameluz® in combination with the red-light lamp BF-RhodoLED® for the treatment of moderate-to-severe acne with photodynamic therapy (Ameluz®-PDT).

5 Day Chart Technical Analysis

I like the stock! Great news and the 5 day is bullish and has solid news with a patent being accepted and a phase 2b clinical trial being announced. 

1 Day Chart Technical Analysis

Technical Analysis:

I like the stock only IF the bearish trend continues in the morning, stay AWAY until there is consolidation and a double confirmation of a bullish move. 

Stay in the lopp :

Affinity Beverage Group Inc (OTCMKTS:ABVG) An...
Affinity Beverage Group Inc (OTCMKTS:ABVG) shares rose 33.33% on Friday to $0.00040 and were unchanged in after-hours trading. Share prices have been trading in
Netlist NLST is ready to take off?

Netlist NLST is ready to take off is a loaded question and it depends on a few factors. However, before we get into

Here Are The Next Major Catalysts To Watch Fr...
VBI Vaccines, Inc. - Ordinary Shares (NASDAQ:VBIV) has had a strong start to 2017, currently trading for a circa 22% premium on it's December close

related post

Skip to content